-
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
de Jong, H. M. Y., van Mens, L. J. J., Nurmohamed, M. T., Kok, M. R., van Kuijk, A. W. R., Baeten, D. L. P. & van de Sande, M. G. H., 14 Sept 2019, In: Arthritis research & therapy. 21, 1, p. 208 208.Research output: Contribution to journal › Article* › Academic › peer-review
-
Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: A double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate
van Mens, L. J. J., de Jong, H. M., Fluri, I., Nurmohamed, M. T., van de Sande, M. G. H., Kok, M., van Kuijk, A. W. R. & Baeten, D., 1 May 2019, In: Annals of the rheumatic diseases. 78, 5, p. 610-616 7 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement: discordance between the rheumatologist's opinion and minimal disease activity measurement
van Mens, L. J. J., Turina, M. C., van de Sande, M. G. H., Nurmohamed, M. T., van Kuijk, A. W. R. & Baeten, D. L. P., 1 Feb 2018, In: Rheumatology (Oxford, England). 57, 2, p. 283-290 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications